Amplimmune is a product driven company that is developing broad spectrum immune-based biologics to treat patients in the areas of cancer,
autoimmunity, transplantation and infectious diseases. These immunomodulatory molecules are the basis for developing a new class of biological
treatments which modulate the immune system with the aim of bettering lives of patients suffering from aberrant immunological conditions.